SG11202101919VA - Manufacturing method for 4-methoxypyrrole derivatives - Google Patents

Manufacturing method for 4-methoxypyrrole derivatives

Info

Publication number
SG11202101919VA
SG11202101919VA SG11202101919VA SG11202101919VA SG11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA
Authority
SG
Singapore
Prior art keywords
manufacturing
methoxypyrrole derivatives
methoxypyrrole
derivatives
Prior art date
Application number
SG11202101919VA
Other languages
English (en)
Inventor
Jeong Taek Shin
Jeong Hyun Son
Deok Ki Eom
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Priority claimed from PCT/KR2019/012122 external-priority patent/WO2020060213A1/ko
Publication of SG11202101919VA publication Critical patent/SG11202101919VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SG11202101919VA 2018-09-19 2019-09-19 Manufacturing method for 4-methoxypyrrole derivatives SG11202101919VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180112196 2018-09-19
KR1020190110997A KR102126576B1 (ko) 2018-09-19 2019-09-06 4-메톡시 피롤 유도체의 제조 방법
PCT/KR2019/012122 WO2020060213A1 (ko) 2018-09-19 2019-09-19 4-메톡시 피롤 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
SG11202101919VA true SG11202101919VA (en) 2021-04-29

Family

ID=69959291

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101919VA SG11202101919VA (en) 2018-09-19 2019-09-19 Manufacturing method for 4-methoxypyrrole derivatives

Country Status (21)

Country Link
US (1) US12110271B2 (ja)
EP (1) EP3854784A4 (ja)
JP (1) JP7253624B2 (ja)
KR (1) KR102126576B1 (ja)
CN (1) CN112739684B (ja)
AU (1) AU2019343857B2 (ja)
BR (1) BR112021005156A2 (ja)
CA (1) CA3110830A1 (ja)
CL (1) CL2021000639A1 (ja)
CO (1) CO2021003195A2 (ja)
DO (1) DOP2021000042A (ja)
EC (1) ECSP21019076A (ja)
JO (1) JOP20210040A1 (ja)
MA (1) MA53673A (ja)
MX (1) MX2021003137A (ja)
PE (1) PE20211736A1 (ja)
PH (1) PH12021550523A1 (ja)
RU (1) RU2763287C1 (ja)
SA (1) SA521421372B1 (ja)
SG (1) SG11202101919VA (ja)
TN (1) TN2021000035A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN116761589A (zh) 2020-12-18 2023-09-15 株式会社大熊制药 含1-(5-(2,4-二氟苯基)-1-((3-氟苯基)磺酰基)-4-甲氧基-1h-吡咯-3-基)-n-甲基甲胺的口服给药新制剂
KR102556500B1 (ko) * 2021-11-19 2023-07-19 하나제약 주식회사 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물
WO2023229323A1 (ko) * 2022-05-23 2023-11-30 일동제약(주) 6-메톡시피리딘-3-일 유도체의 제조방법
WO2023229322A1 (ko) * 2022-05-23 2023-11-30 일동제약(주) 6-메톡시피리딘-3-일 유도체의 제조방법
CN117820193A (zh) * 2022-09-29 2024-04-05 安徽皓元药业有限公司 一种非苏拉赞盐酸盐晶型a及其制备方法
KR20240127136A (ko) * 2023-02-15 2024-08-22 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592996A (en) 1977-10-10 1981-07-15 Rolland Sa A Acylated pyrrole carboxylic acids and derivatives thereof
HU228844B1 (en) 2001-05-24 2013-06-28 Lilly Co Eli Pyrrole derivatives and pharmaceutical compositions containing them
US7691837B2 (en) 2002-09-20 2010-04-06 Lupin Limited Pyrrole derivatives as antimycobacterial compounds
ES2402362T3 (es) * 2004-09-30 2013-05-03 Takeda Pharmaceutical Company Limited Inhibidores de la bomba de protones
PE20110009A1 (es) 2005-08-30 2011-01-31 Takeda Pharmaceutical Derivados de pirrol como inhibidores de la secrecion acida
JP5207964B2 (ja) 2006-03-31 2013-06-12 武田薬品工業株式会社 酸分泌抑制薬
US7741364B2 (en) 2006-06-27 2010-06-22 Abbott Laboratories Pyrrole derivatives and their methods of use
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2009137657A1 (en) 2008-05-08 2009-11-12 Bristol-Myers Squibb Company 2-aryl glycinamide derivatives
UY32008A (es) 2008-07-28 2010-02-26 Takeda Pharmaceutical Composición farmacéutica
US8969387B2 (en) 2008-08-27 2015-03-03 Takeda Pharmaceutical Company Limited Pyrrole compounds
US8895558B2 (en) 2008-10-02 2014-11-25 Green Cross Corporation Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
GB0823003D0 (en) 2008-12-17 2009-01-28 Syngenta Participations Ag Pyrrole derivatives with plant growth regulating properties
AU2013347383B2 (en) * 2012-11-19 2017-04-06 Jiangsu Hansoh Pharmaceutical Co., Ltd. Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
BR112015025729B1 (pt) 2013-04-10 2023-04-25 Daiichi Sankyo Company, Limited Métodos para resolver e para produzir um composto
JP2017071553A (ja) 2014-02-25 2017-04-13 味の素株式会社 ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
CN104447491B (zh) 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
KR101613245B1 (ko) 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
CN106432191A (zh) * 2015-08-10 2017-02-22 陕西合成药业股份有限公司 一种新的吡咯类衍生物、其制备方法及其在医药上的应用
WO2017164575A1 (en) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
KR20170113040A (ko) 2016-03-25 2017-10-12 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염
KR102081920B1 (ko) * 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
CN107879964B (zh) * 2016-09-29 2023-02-10 江苏柯菲平医药股份有限公司 1-(5-(2-氟苯基)-1-(3-(3-甲氧丙氧基)苯磺酰氯)-1h-吡咯-3-基)-n-甲基胺的制备方法
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102233455B1 (ko) 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN108503621B (zh) * 2017-12-25 2021-09-14 上海中拓医药科技有限公司 一种富马酸沃诺拉赞的制备方法
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
WO2020060213A1 (ko) 2018-09-19 2020-03-26 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
MX2023013985A (es) 2021-05-26 2023-12-12 Daewoong Pharmaceutical Co Ltd Contenedor de medicina que comprende la composicion farmaceutica liquida de 1-(5-(2,4-difluorofenil)-1-((3-fluorofenil)sulfonil)-4- metoxi-1h-pirrol-3-il)-n-metilmetanamina.

Also Published As

Publication number Publication date
AU2019343857B2 (en) 2021-12-02
SA521421372B1 (ar) 2024-01-25
PE20211736A1 (es) 2021-09-06
CO2021003195A2 (es) 2021-04-08
NZ773997A (en) 2024-03-22
CN112739684B (zh) 2024-06-04
KR20200033178A (ko) 2020-03-27
US12110271B2 (en) 2024-10-08
AU2019343857A1 (en) 2021-04-15
JP7253624B2 (ja) 2023-04-06
MA53673A (fr) 2022-03-30
JP2021535934A (ja) 2021-12-23
MX2021003137A (es) 2021-05-14
RU2763287C1 (ru) 2021-12-28
CA3110830A1 (en) 2020-03-26
ECSP21019076A (es) 2021-05-31
KR102126576B1 (ko) 2020-06-24
BR112021005156A2 (pt) 2021-06-15
CN112739684A (zh) 2021-04-30
PH12021550523A1 (en) 2022-02-21
CL2021000639A1 (es) 2021-08-06
TN2021000035A1 (en) 2022-10-03
EP3854784A1 (en) 2021-07-28
DOP2021000042A (es) 2021-05-31
JOP20210040A1 (ar) 2021-03-07
EP3854784A4 (en) 2022-03-30
US20210221770A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
SG11202101919VA (en) Manufacturing method for 4-methoxypyrrole derivatives
GB201800298D0 (en) Method
IL283331A (en) Method for the preparation of n-phenylpyrazole-1-carboxamides
GB201800558D0 (en) Method
PL4046129T3 (pl) Sposób wytwarzania
IL271024A (en) A method for producing cement
EP3677548A4 (en) PROCESS FOR PRODUCING ULTRA-POROUS NANO-SIO2
ZA202109841B (en) Method for manufacturing mortar-based elements
PL3733651T3 (pl) Sposób wytwarzania kalkobutrolu
GB201804277D0 (en) Method
SG11201908162RA (en) Method for manufacturing wafer
GB201803750D0 (en) Method
SG11202007901YA (en) Method for manufacturing instant noodles
EP3550058A4 (en) METHOD FOR MANUFACTURING A STRUCTURE
GB201802653D0 (en) Method
GB201800187D0 (en) Method
IL279070A (en) A method for the production of diarylpyridine derivatives
IL282108A (en) A method for preparing epiconazole
GB2588550B (en) Method for manufacturing custom products
SG11202103673UA (en) Method for producing perfluorocycloalkene compound
SG11202005507SA (en) Method for manufacturing methionine
GB201804289D0 (en) Method
GB201803183D0 (en) Method
GB201802744D0 (en) Method
GB201801169D0 (en) Method